Moreover, we observed that significant improvements in external appearance after AuNPs/dCas9 mediated Oct4 activation, including a reduction in the spine curvature in the progeria mice treated with the dCas9‐Oct4 activator (Figure 4e). The gene discussed is POU5F1; the disease is progeroid syndrome.